NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Back to Results
Pulmonary and Systemic Immune Response to Chronic Lunar Dust InhalationBackground: Due to millennia of meteorite impact with virtually no erosive effects, the surface of the Moon is covered by a layer of ultra‐fine, reactive Lunar dust. Very little is known regarding the toxicity of Lunar dust on human physiology. Given the size and electrostatic characteristics of Lunar dust, countermeasures to ensure non‐exposure of astronauts will be difficult. To ensure astronaut safety during any future prolonged Lunar missions, it is necessary to establish the effect of chronic pulmonary Lunar dust exposure on all physiological systems. Methods: This study assessed the toxicity of airborne lunar dust exposure in rats on pulmonary and system immune system parameters. Rats were exposed to 0, 20.8, or 60.8 mg/m3 of lunar dust (6h/d; 5d/wk) for up to 13 weeks. Sacrifices occurred after exposure durations of 1day, 7 days, 4 weeks and 13 weeks post‐exposure, when both blood and lung lavage fluid were collected for analysis. Lavage and blood assays included leukocyte distribution by flow cytometry, electron/fluorescent microscopy, and cytokine concentration. Cytokine production profiles following mitogenic stimulation were performed on whole blood only. Results: Untreated lavage fluid was comprised primarily of pulmonary macrophages. Lunar dust inhalation resulted in an influx of neutrophils and lymphocytes. Although the percentage of lymphocytes increased, the T cell CD4:CD8 ratio was unchanged. Cytokine analysis of the lavage fluid showed increased levels of IL‐1b and TNFa. These alterations generally persisted through the 13 week sampling. Blood analysis showed few systemic effects from the lunar dust inhalation. By week 4, the peripheral granulocyte percentage was elevated in the treated rats. Plasma cytokine levels were unchanged in all treated rats compared to controls. Peripheral blood analysis showed an increased granulocyte percentage and altered cytokine production profiles consisting of increased in IL‐1b and IL‐6, and decreased IL‐2 production. Conclusion: Lunar dust inhalation results in significant lung inflammation, and some systemic effects, that does not resolve through 13 weeks. Lunar dust may therefore represent a crew health risk during sortie or long‐duration Lunar missions.
Document ID
20140013073
Acquisition Source
Johnson Space Center
Document Type
Abstract
Authors
Crucian, Brian
(NASA Johnson Space Center Houston, TX, United States)
Quiriarte, Heather
(Wyle Integrated Science and Engineering Group Houston, TX, United States)
Nelman, Mayra
(Wyle Integrated Science and Engineering Group Houston, TX, United States)
Lam, Chiu-wing
(Wyle Integrated Science and Engineering Group Houston, TX, United States)
James, John T.
Sams, Clarence
(NASA Johnson Space Center Houston, TX, United States)
Date Acquired
October 16, 2014
Publication Date
June 16, 2014
Subject Category
Aerospace Medicine
Lunar And Planetary Science And Exploration
Report/Patent Number
JSC-CN-30746
Meeting Information
Meeting: Annual International Gravitational Physiology Meeting
Location: Waterloo, ON
Country: Canada
Start Date: June 16, 2014
End Date: June 20, 2014
Sponsors: International Society for Gravitational Physiology, European Space Agency. Centre Spatial de Toulouse, Canadian Space Agency
Distribution Limits
Public
Copyright
Public Use Permitted.
No Preview Available